Wedbush downgrades ZymoGenetics (ZGEN) to Neutral; Bristol-Myers (BMY) Steps in at $9.75
Tweet Send to a Friend
Wedbush downgrades ZymoGenetics, Inc. (Nasdaq: ZGEN) from Outperform to Neutral. Raises PT from $9 to $9.75.
Wedbush analyst says, "Bristol-Myers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Bristol-Myers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
